Home KP EU C.V.

KP EU C.V.

In operation
-
Cell Therapy Researcher
Basic
Enterprise Profile

Basic Information

KP EU C.V., a subsidiary of Gilead Sciences, Inc., is established in the Netherlands. The company develops cell therapies to treat and potentially cure cancer.
KP EU C.V.
Netherlands
unclear
October 05, 2018
--
--

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy
Technology
Cell Technology
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs Cell and Gene Therapy